Literature DB >> 21344021

Subendocardial fibrosis in left ventricular hypertrabeculation-cause or consequence?

J Ker1, L Du Toit-Prinsloo, W F P Van Heerden, G Saayman.   

Abstract

Left ventricular noncompaction has been classified as a primary cardiomyopathy with a genetic origin. This condition is morphologically characterized by a thickened, two-layered myocardium with numerous prominent trabeculations and deep, intertrabecular recesses. Recently, it has become clear that these pathological characteristics extend across a continuum with left ventricular hypertrabeculation at one end of the spectrum.The histological findings include areas of interstitial fibrosis.We present a case of left ventricular hypertrabeculation which presented as sudden infant death syndrome. Histologically areas of subendocardial fibrosis was prominent and we propose that this entity may be a hidden cause of arrhythmic death in some infants presenting as sudden infant death syndrome., with areas of subendocardial fibrosis as possible arrhythmogenic foci.

Entities:  

Keywords:  fibrosis; hypertrabeculation; noncompaction; sudden infant death syndrome

Year:  2011        PMID: 21344021      PMCID: PMC3041236          DOI: 10.4137/CMC.S6507

Source DB:  PubMed          Journal:  Clin Med Insights Cardiol        ISSN: 1179-5468


Introduction

Left ventricular noncompaction has been classified as a primary cardiomyopathy with a genetic origin.1 Morphologically, this condition is characterized by a thickened, two-layered myocardium with numerous and prominent trabeculations and deep, intertrabecular recesses.1–3 Left ventricular noncompaction may be an isolated finding or it may be associated with a variety of other congenital heart defects.1 Left ventricular noncompaction is associated with numerous sarcomere mutations and this fact created the view that there is a spectrum spanning hypertrophic cardiomyopathy (especially apical HCM), dilated cardiomyopathy and left ventricular noncompaction.4 Current diagnostic criteria for left ventricular noncompaction require the visualization of two distinct myocardial layers.5 The work of Stöllberger departs from this stipulation and he coined the term “left ventricular hypertrabeculation”.5 This entity, which can be viewed as a less severe form of noncompaction, is characterized by the presence of more than three trabeculations located apically to the papillary muscles.5

Case Report and Discussion

We present a case report of a three month old male infant who presented with sudden infant death syndrome. The macroscopical characteristics of this case was reported before.6 This three month old non-caucasian died suddenly and unexpectedly at his day care centre. He did not have any known medical problems and no surgical procedures were ever performed. No known allergies were present and no known family history of sudden, unexpected death were present. Unfortunately the family members were lost to follow up, before electrocardiographic and echocardiographic screening could be performed to assess their risk for sudden unexpected death. Postmortem examination of the heart revealed numerous apical trabeculations of the left ventricle (see Fig. 1). The right ventricle appeared perfectly normal. The left ventricular wall thickness measured 1 cm. No abnormalities were detected in any other organs during the postmortem examination and no thrombi were detected in the arterial system or the left ventricle.
Figure 1.

Note the numerous trabeculations in the apex of the left ventricle. More than three trabeculations distal to the level of the papillary muscles is present, thus fulfilling the criterion for the diagnosis of left ventricular hypertrabeculation.

Figure 1 clearly demonstrates more than three trabeculations in the left ventricle in a location apical to the papillary muscles. According to Stöllberger7,8 this case which presented as a sudden infant death syndrome thus fulfills the criterion for left ventricular hypertrabeculation. Histological assessment of sections underlying the left ventricular trabeculae revealed prominent areas of subendocardial fibrosis (see Figs. 2, 3 and 4).
Figure 2.

Histological sections with a Masson stain of the apex of the left ventricle. Note the areas of subendocardial and interstitial fibrosis.

Figure 3.

Histological sections with a Masson stain of the apex of the left ventricle. Note the areas of subendocardial and interstitial fibrosis.

Figure 4.

Histological sections with a Masson stain of the apex of the left ventricle. Note the areas of subendocardial and interstitial fibrosis.

Figure 5 is a histological section of the apex of the left ventricle of a three month old male infant who also presented as a sudden infant death syndrome, but without left ventricular hypertrabeculation to serve as a control.
Figure 5.

Histological section with a Masson stain of the apex of the left ventricle of the control case of sudden infant death syndrome, but without left ventricular hypertrabeculation.

Endocardial fibrosis with prominent elastin deposition have been described in cases of left ventricular noncompaction.5,9,10 Currently, it is thought that ischaemia may play a major role in the pathogenesis of left ventricular noncompaction: MRI and thallium-201 scintigraphy has shown subendocardial and transmural perfusion defects which corresponds to areas of noncompacted myocardium.5,11–14 Reduced coronary flow reserve, indicating microvascular dysfunction has also been shown to be present in isolated ventricular noncompaction by PET.12 Currently, a “chicken and egg” dilemma exists regarding the pathogenesis of isolated ventricular noncompaction: either an impairment in the development of the myocardial microcirculation impairs the normal compaction process of the myocardium or vice versa. In this case report we describe subendocardial fibrosis in a three month old infant with left ventricular hypertrabeculation. Current literature notes the presence of fibrosis in cases of ventricular noncompaction, this is the first case describing fibrosis in ventricular hypertrabeculation—the less severe form of noncompaction. Secondly, the presence of such striking subendocardial fibrosis implies that the involved areas in the left ventricle must experience ischaemia already in utero. Lastly, we propose that these fibrotic areas may act as the foci of ventricular arrhythmia as the underlying cause of death.

Contribution from Different Authors

J Ker did the literature review and writing. L Du-Toit-Prinsloo, WFP Van Heerden and G Saayman did the post-mortem analysis and histological assessment.
  14 in total

1.  Isolated noncompaction of the myocardium.

Authors:  R Jenni; J Rojas; E Oechslin
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

2.  Isolated noncompaction of the ventricular myocardium: ultrafast computed tomography and magnetic resonance imaging.

Authors:  Y Hamamichi; F Ichida; I Hashimoto; K H Uese; T Miyawaki; S Tsukano; Y Ono; S Echigo; T Kamiya
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

3.  MRI of subendocardial perfusion deficits in isolated left ventricular noncompaction.

Authors:  Rafaela Soler; Esther Rodríguez; Lorenzo Monserrat; Nemesio Alvarez
Journal:  J Comput Assist Tomogr       Date:  2002 May-Jun       Impact factor: 1.826

4.  Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders.

Authors:  Claudia Stöllberger; Josef Finsterer; Gerhard Blazek
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

5.  Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals.

Authors:  S B Bleyl; B R Mumford; M C Brown-Harrison; L T Pagotto; J C Carey; T J Pysher; K Ward; T K Chin
Journal:  Am J Med Genet       Date:  1997-10-31

6.  Isolated ventricular noncompaction is associated with coronary microcirculatory dysfunction.

Authors:  Rolf Jenni; Christophe A Wyss; Erwin N Oechslin; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

7.  Myocardial ischaemia in children with isolated ventricular non-compaction.

Authors:  G Junga; S Kneifel; A Von Smekal; H Steinert; U Bauersfeld
Journal:  Eur Heart J       Date:  1999-06       Impact factor: 29.983

8.  Left ventricular noncompaction: a pathological study of 14 cases.

Authors:  Allen Burke; Erik Mont; Robert Kutys; Renu Virmani
Journal:  Hum Pathol       Date:  2005-04       Impact factor: 3.466

9.  Sudden infant death syndrome and left ventricular hypertrabeculation-hidden arrhythmogenic entity?

Authors:  J Ker; L Du Toit-Prinsloo; W F P van Heerden; G Saayman
Journal:  Clin Med Insights Cardiol       Date:  2010-09-17

10.  Mutations in sarcomere protein genes in left ventricular noncompaction.

Authors:  Sabine Klaassen; Susanne Probst; Erwin Oechslin; Brenda Gerull; Gregor Krings; Pia Schuler; Matthias Greutmann; David Hürlimann; Mustafa Yegitbasi; Lucia Pons; Michael Gramlich; Jörg-Detlef Drenckhahn; Arnd Heuser; Felix Berger; Rolf Jenni; Ludwig Thierfelder
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

View more
  4 in total

Review 1.  Fetal Ventricular Hypertrabeculation/Noncompaction: Clinical Presentation, Genetics, Associated Cardiac and Extracardiac Abnormalities and Outcome.

Authors:  Claudia Stöllberger; Christian Wegner; Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2015-05-27       Impact factor: 1.655

Review 2.  Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors.

Authors:  Josef Finsterer; Claudia Stöllberger; Jeffrey A Towbin
Journal:  Nat Rev Cardiol       Date:  2017-01-12       Impact factor: 32.419

3.  Specification of the Myopathy Type may Influence the Management of Noncompaction.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Heart Views       Date:  2016 Jul-Sep

Review 4.  Left ventricular noncompaction: a disorder with genotypic and phenotypic heterogeneity-a narrative review.

Authors:  Keiichi Hirono; Fukiko Ichida
Journal:  Cardiovasc Diagn Ther       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.